Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality

Lancet Respir Med. 2014 Jul;2(7):e10-2. doi: 10.1016/S2213-2600(14)70137-7. Epub 2014 Jun 16.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Enzyme Inhibitors / therapeutic use*
  • Female
  • Humans
  • Influenza A Virus, H1N1 Subtype*
  • Influenza, Human / drug therapy*
  • Male
  • Neuraminidase / antagonists & inhibitors*
  • Oseltamivir / therapeutic use*
  • Pandemics*
  • Zanamivir / therapeutic use*

Substances

  • Antiviral Agents
  • Enzyme Inhibitors
  • Oseltamivir
  • Neuraminidase
  • Zanamivir